ATE543805T1 - Verfahren zur herstellung von oxazolidinonderivaten - Google Patents

Verfahren zur herstellung von oxazolidinonderivaten

Info

Publication number
ATE543805T1
ATE543805T1 AT08170827T AT08170827T ATE543805T1 AT E543805 T1 ATE543805 T1 AT E543805T1 AT 08170827 T AT08170827 T AT 08170827T AT 08170827 T AT08170827 T AT 08170827T AT E543805 T1 ATE543805 T1 AT E543805T1
Authority
AT
Austria
Prior art keywords
oxazolidinone derivatives
producing
producing oxazolidinone
derivatives
linezolid
Prior art date
Application number
AT08170827T
Other languages
English (en)
Inventor
Lino Colombo
Pietro Allegrini
Marco Brusasca
Arienzo Giuseppe D
Gabriele Razzetti
Original Assignee
Dipharma Francis Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dipharma Francis Srl filed Critical Dipharma Francis Srl
Application granted granted Critical
Publication of ATE543805T1 publication Critical patent/ATE543805T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/135—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT08170827T 2007-12-18 2008-12-05 Verfahren zur herstellung von oxazolidinonderivaten ATE543805T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT002359A ITMI20072359A1 (it) 2007-12-18 2007-12-18 Procedimento per la preparazione di derivati ossazolidinonici

Publications (1)

Publication Number Publication Date
ATE543805T1 true ATE543805T1 (de) 2012-02-15

Family

ID=40315597

Family Applications (1)

Application Number Title Priority Date Filing Date
AT08170827T ATE543805T1 (de) 2007-12-18 2008-12-05 Verfahren zur herstellung von oxazolidinonderivaten

Country Status (4)

Country Link
US (1) US20090156806A1 (de)
EP (1) EP2072505B1 (de)
AT (1) ATE543805T1 (de)
IT (1) ITMI20072359A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2033960A3 (de) 2007-09-04 2009-04-29 Dipharma Francis S.r.l. Kristalline Linezolidhydratform und Linezolidsalze
US9586913B2 (en) 2013-04-25 2017-03-07 Symed Labs Limited Processes for the preparation of linezolid using novel intermediates
CN103804315B (zh) * 2014-02-20 2015-12-09 四川大学 一种5-氨甲基噁唑烷酮类化合物的制备方法
CN105111160B (zh) * 2015-09-11 2017-04-12 浙江新东港药业股份有限公司 一种利奈唑胺的制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY115155A (en) * 1993-09-09 2003-04-30 Upjohn Co Substituted oxazine and thiazine oxazolidinone antimicrobials.
US5839870A (en) * 1996-03-13 1998-11-24 Novus Corporation Transfer system for use with a horizontal furnace
NZ504372A (en) * 1997-11-07 2002-12-20 Upjohn Co Process to produce N-[3-fluoro-4(4-morpholinyl)phenyl]-2-oxo-5-oxazolidinones
US6444813B2 (en) * 2000-02-02 2002-09-03 Pharmacia & Upjohn Company Linezolid-crystal form II
ATE321024T1 (de) * 2000-10-17 2006-04-15 Pharmacia & Upjohn Co Llc Verfahren zur herstellung von oxazolidinonverbindungen
ATE374463T1 (de) * 2001-04-20 2007-10-15 Pharmacia & Upjohn Co Llc Verfahren zur herstellung von oxazolidinonen
EP1658275A1 (de) * 2004-06-29 2006-05-24 Teva Pharmaceutical Industries Ltd Kristalline form iv von linezolid
EP1745028A2 (de) * 2004-06-29 2007-01-24 Teva Pharmaceutical Industries Ltd Linezolid in fester form und herstellungsverfahren dafür

Also Published As

Publication number Publication date
EP2072505A2 (de) 2009-06-24
ITMI20072359A1 (it) 2009-06-19
US20090156806A1 (en) 2009-06-18
EP2072505B1 (de) 2012-02-01
EP2072505A3 (de) 2009-08-12

Similar Documents

Publication Publication Date Title
WO2009063505A3 (en) Process for preparation of (s) (n-[[3-[3-fluoro-4-(4-morpholinyl) hen l -2-oxo-5-oxazolidin l methyl]acetamide
EP2300528A4 (de) Verfahren zur herstellung von kunstlatex
TW200914429A (en) Method for preparing 5-haloalkyl-4,5-dihydroisoxazole derivatives
DE50313496D1 (de) VERFAHREN ZUR HERSTELLUNG VON 5-CHLOR- i N /i -({5S)-2-OXO-3- 4-(3-OXO-4-MORPHOLINYL)-PHENYL -1,3-OXAZOLIDIN-5-YL&r cub;-METHYL)-2-THIOPHENCARBOXAMID
DE602005018981D1 (de) Verfahren zur Herstellung von L-Cystein, und L-Cystein-produzierender Mikroorganismus
DE602005027395D1 (de) Verfahren zur herstellung in maschinenquerrichtung elastische materialien
EP2216336A4 (de) Verfahren zur herstellung von zyklischem polyorganosiloxan, härtemittel, härtbare zusammensetzung und härteprodukt aus der härtbaren zusammensetzung
PE20141943A1 (es) Antagonistas de trpv4
ATE416766T1 (de) Verfahren zur herstellung von 4-(2- dipropylaminoethyl)-1,3-dihydro-2h-indol-2-on- hydrochlorid
ATE321024T1 (de) Verfahren zur herstellung von oxazolidinonverbindungen
EP1792899A4 (de) Verfahren zur herstellung von optisch aktiven aminderivaten
EA201391647A1 (ru) Способ получения ривароксабана и промежуточные соединения, получаемые в указанном способе
PE20091431A1 (es) Compuestos derivados de azetidinas, su preparacion y su aplicacion en terapeutica
DE112005003155T8 (de) Verfahren zur Herstellung eines Wegwerftrageartikels
DE602006017918D1 (de) Verfahren zur Herstellung von Telmisartan
PE20120667A1 (es) 2-mercapto-3-aminopiridina sustituida como moduladores de kcnq2/3
EP2072505A3 (de) Verfahren zur Herstellung von Oxazolidinonderivaten
ATE372336T1 (de) Prozess zur herstellung von pioglitazon via verschiedene zwischenstufen
DE602005003791D1 (de) Verfahren zur herstellung von 1-(2s,3s)-2-benzhydril-n-(5-tert.-butyl-2-methoxybenzyl)chinuklidin-3-amin
EP2040906A4 (de) Verfahren und vorrichtung zum kühlen eines formkörpers nach dem formen
DE502004011562D1 (de) Verfahren zur herstellung neuer tiotropiumsalze
DE502005001841D1 (de) Verfahren zur herstellung von 1,4-diphenylazetidinon-derivaten
DE602004003037D1 (de) Verfahren und zwischenprodukte für die herstellung von emtricitabin
DE602005018238D1 (de) Halbsynthetisches verfahren zur herstellung von 10-desacetyl-n-desbenzoyl-paclitaxel
DE602005021110D1 (de) Verfahren zur herstellung von n-piperidino-1,5-diphenylpyrazol-3-carboxamid-derivaten